Harap, Anaclito T.
HRN: 29-03-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2026
CEFTAZIDIME 1GM (VIAL)
07/14/2026
07/20/2026
IV
2g
Q8h
CAP-MR
Checking Final Appropriateness
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes